Dr. James Charles Fox has served as Independent NonExecutive Chairman of the Board of Biota Holdings Ltd since February 27, 2009. Within the Company, he is Member of the Remuneration and Nominations Committee. He has held directorship positions at Air New Zealand Limited, MS Research Ltd, GenMark Diagnostics, Inc and TTP Group PLC. He was formerly Chief Executive Officer of Vision Systems, which he led until its takeover by an Ameriacan company, Danaher. Prior to that, he held directorships at Optiscan Imaging Limited, Elders Limited and ISoft Group Ltd. He also spent seven years working as a Consultant and Director with PA Technology. He holds a Bachelor of Engineering, as well as Masters and Doctorate degrees from the University of Melbourne.
The company has return on total asset (ROA) of (15.95) % which means that it has lost $15.95 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (27.83) % meaning that it generated substantial loss on money invested by shareholders.
Biota Holdings Limited engages in the drug discovery and clinical development of antiinfectives in Australia. Biota Pharmaceuticals Inc [BTA] is traded on Australian Securities Exchange in Australia. It is located in Notting Hill, VIC and employs 15 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
1.03%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Australian
